Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline.

Source:http://linkedlifedata.com/resource/pubmed/id/10992374

Download in:

View as

General Info

PMID
10992374